Colorectal Neoplasia in CDH1 Pathogenic Variant Carriers: A Multicenter Analysis

Am J Gastroenterol. 2022 Nov 1;117(11):1877-1879. doi: 10.14309/ajg.0000000000001996. Epub 2022 Sep 6.

Abstract

Introduction: Germline variants in CDH1 are associated with elevated risks of diffuse gastric cancer and lobular breast cancer. It is uncertain whether there is an increased risk of colorectal neoplasia.

Methods: This was a retrospective analysis of colonoscopy outcomes in patients with germline CDH1 pathogenic/likely pathogenic variants.

Results: Eighty-five patients were included with a mean age of 46.9 years. Initial colonoscopy found adenomatous polyps in 30 patients (35.3%), including advanced adenomas in 9 (10.6%). No colorectal cancers were identified on index or subsequent colonoscopies (when available).

Discussion: CDH1 carriers have colorectal neoplasia identified at similar rates as in the general population. Despite potential difficulties after gastrectomy, colorectal cancer screening remains important in this population.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / genetics
  • Breast Neoplasms*
  • Cadherins / genetics
  • Colonoscopy
  • Colorectal Neoplasms* / diagnosis
  • Colorectal Neoplasms* / genetics
  • Colorectal Neoplasms* / surgery
  • Female
  • Germ-Line Mutation
  • Humans
  • Middle Aged
  • Retrospective Studies

Substances

  • CDH1 protein, human
  • Antigens, CD
  • Cadherins